Помогите, пожалуйста, с:
1
Use of secondary structure element information in drug design: polypharmacology and conserved motifs in protein–ligand binding and protein–protein interfaces
Oliver Koch
Future Medicinal Chemistry
April 2011, Vol. 3, No. 6, Pages 699-708 , DOI 10.4155/fmc.11.26
- DOI:
http://dx.doi.org/10.4155/fmc.11.26
The use of G-protein coupled receptor models in lead optimization
Christofer S. Tautermann
Future Medicinal Chemistry
April 2011, Vol. 3, No. 6, Pages 709-721 , DOI 10.4155/fmc.11.24
- DOI:
http://dx.doi.org/10.4155/fmc.11.24
Binding-interaction prediction of RNA-binding ligands
Tiziano Tuccinardi
Future Medicinal Chemistry
April 2011, Vol. 3, No. 6, Pages 723-733 , DOI 10.4155/fmc.11.25
- DOI:
http://dx.doi.org/10.4155/fmc.11.25